Bioadhesive Compact Matrix Heat Treatment for Zero-Order Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlled release of active substances through polymer matrices often require complex and costly industrial processes, and existing direct compression techniques struggle to achieve prolonged release kinetics independent of the drug dose, with limited success in achieving zero-order release kinetics and stability.
Innovation Solution
A method involving the preparation of compact bioadhesive matrices using a mixture of alkylcellulose or hydroxyalkylcellulose and cross-linked polycarboxylic polymers, subjected to direct compression and heat treatment at 80-250°C for 1-60 minutes, which forms a non-erodible gel layer for prolonged release of active substances.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If direct compression method is used for producing matrix systems, then manufacturing complexity is reduced and production cost is lowered, but the ability to achieve effective prolonged release and control drug release rate is insufficient
Solution Approach 1:
The patent uses a composite polymer system combining hydrophilic polymers (HPMC, carbomer, or polycarbophil) with hydrophobic polymers (ethylcellulose or Eudragit RS/RL). This composite structure enables direct compression manufacturing while achieving effective prolonged release control, as the hydrophilic component swells to form a gel matrix that controls drug diffusion while the hydrophobic component provides structural integrity and prevents premature disintegration.
Solution Approach 2:
The patent optimizes specific parameters including polymer molecular weight, degree of substitution, polymer ratio, particle size distribution, and compression force to achieve prolonged release through direct compression. By carefully controlling these parameters, the system transforms a simple compression process into an effective controlled release formulation without requiring complex granulation steps.
2Reliability
If osmotic systems with semi-permeable membranes are used, then controlled release with zero-order kinetics is achieved, but device complexity increases and production cost rises
Solution Approach 1:
The patent extracts and eliminates the complex semi-permeable membrane component from the osmotic system while retaining the controlled release functionality. By using a simplified matrix system composed of swelling hydrophilic polymers and hydrophobic structuring agents, the invention achieves zero-order release kinetics without requiring laser-drilled holes, osmotic agents, or multi-layer membrane structures.
Solution Approach 2:
The patent replaces expensive, complex engineered osmotic systems with a simpler, more economical matrix system using readily available pharmaceutical polymers. The direct compression process further reduces manufacturing costs while achieving comparable controlled release performance, making the system more suitable for commercial pharmaceutical production.
3Speed
If polymer matrices with high erosion rates are used, then drug release is accelerated, but unpredictable release kinetics and dumping dose phenomenon occur
Solution Approach 1:
The patent introduces a gel layer formed by swelling hydrophilic polymers as an intermediary between the drug core and the external environment. This gel layer acts as a diffusion barrier that controls drug release rate and prevents rapid erosion-induced dumping. The gel structure provides predictable sustained release kinetics while maintaining reasonable release speed, eliminating the harmful effects of high erosion rates.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a controlled and prolonged release of active substances with zero-order kinetics, maintaining release rate consistency over time, and demonstrates stability and effectiveness in various environmental conditions, including gastric and intestinal simulations.
Implementation Method 1
a non-water-soluble, water-swellable, cross-linked, polycarboxylic polymer
Implementation Method 2
forming a non-erodible gel layer
Implementation Method 3
subjecting the compressed or compacted units thus obtained to heating at a temperature in the range of 80-250° C. for a time in the range of 1-60 minutes
Implementation Method 4
preparing compressed or compacted units starting from said powder mixture by direct compression or dry compaction
Data Source
AI summary
A method for the preparation of a bioadhesive compact matrix, which comprises the preparation of a uniform mixture of powders comprising one alkylcellulose or one hydroxy alkylcellulose and a non-water-soluble, water-swellable crosslinked polycarboxylic polymer; the preparation of compressed units starting from such powder mixture by direct compression and finally the heating of the compressed units thus obtained to a temperature in the range of 80-250° C. for a time of 1-60 minutes; the powder mixture can also comprise at least one active substance and the compressed units thus obtained are characterized by a prolonged release, and have a release kinetics of the active substance substantially of zero order in an aqueous solution at pH 4-8.